Orbital-Built (ORB) Reports Geosynchronous Satellites Launched Aug 1, 2014 04:08PM

Orbital Sciences Corporation (NYSE: ORB) announced today that three satellites the company designed, built and tested for the U.S. Air Force were successfully deployed following their launch aboard a Delta IV rocket from Cape Canaveral, FL on July 28, 2014. These deployments continued Orbital’s “summer surge” of operational activity that has included the fourth launch of its Antares rocket which deployed the third Cygnus cargo logistics spacecraft, a launch of the company’s OBV long-range missile defense interceptor, the deployment of the Orbiting Carbon Observatory-2 satellite for NASA, and the successful launch of three suborbital research rockets, all of which took place since late June.

This week’s launch carried two Orbital-built satellites for the Air Force’s Geosynchronous Space Situational Awareness Program (GSSAP). The spacecraft will operate in near-geosynchronous orbit, collecting Space Situational Awareness (SSA) data for more accurate characterization of man-made objects in Earth orbit. The goal of the program is to enhance the country’s knowledge of the geosynchronous orbit environment for more timely and accurate orbit predictions to improve spaceflight safety.

The Delta IV rocket also carried the Automated Navigation and Guidance Experiment for Local Space (ANGELS) satellite, another Orbital-built spacecraft for the Air Force Research Laboratory (AFRL). As part of AFRL’s research in the SSA field, the ANGELS program will examine techniques for providing a clearer picture of the environment around the country’s vital space assets. The ANGELS spacecraft will conduct experiments in close proximity to the spent upper stage of the Delta IV rocket that launched it into orbit. The Air Force will use the results to evolve the ability of future space systems to responsively perform SSA activities from a safe distance from observed objects.

“The capabilities of the GSSAP and ANGELS satellites demonstrate Orbital’s innovative operational approaches in support of our customers’ vital missions,” said Mr. Christopher Long, Orbital’s Senior Vice President of National Security Satellite Programs.

Zogenix (ZGNX) Chief Commercial Officer Scott Shively Departs Aug 1, 2014 04:06PM

Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Scott Shively has resigned as Chief Commercial Officer in order to pursue another opportunity. In the interim, Roger Hawley, the Company's Chief Executive Officer, will assume the duties and responsibilities of the Chief Commercial Officer and lead the continued launch and commercial activities.

"Scott has laid a solid foundation for our expanded commercial team and we wish him success in his new endeavor," commented Roger Hawley, Chief Executive Officer. "Our experienced commercial team is already fully engaged in carrying out all planned activities and we expect continued growth without disruption. I look forward to leading the sales, marketing, managed care and trade teams to further direct focus to the commercial success of the Company."

Mr. Hawley, one of the co-founders of Zogenix, has extensive experience in leading commercial organizations with his prior experience at multiple pharmaceutical companies.

WI-LAN (WILN) Wins Appeals Court Ruling in Ericsson Litigation Aug 1, 2014 03:28PM

WI-LAN (NASDAQ: WILN) announced that the U.S. Court of Appeals for the Federal Circuit has ruled entirely in WiLAN's favor concerning the proper interpretation of a contract entered into by WiLAN and Ericsson, Inc. and Telefonaktiebolaget LM Ericsson (collectively, "Ericsson"), to resolve a conflict concerning WiLAN's litigation counsel.

Conflicting court decisions had been rendered by District Courts in Texas and Florida concerning the proper interpretation of the contract with Ericsson, the Texas decision being consistent with WiLAN's position that the rights granted to Ericsson were very narrow.

"We are very pleased with this ruling," said Jim Skippen, President & CEO. "We hope this decision brings Ericsson closer to a negotiated resolution of our patent disputes."

Matthew Powers of Tensegrity Law Group, LLP argued for WiLAN. On the brief were David B. Weaver, Stephen M. Hash, Avelyn M. Ross and Ajeet P. Pai of Vinson & Elkins, LLP.

WiLAN is entitled to its costs in the appeal.

General Cable (BGC) Declines, SEC Probe Disclosed in 10-Q Aug 1, 2014 03:14PM

General Cable (NYSE: BGC) declined after filings showed an SEC probe.

"The SEC has issued a formal order of investigation. Pursuant to that formal order, the SEC has issued subpoenas to us seeking relevant documents and to certain current and former employees seeking their testimony. We continue to cooperate with the SEC in connection with its investigation," the company said.

Phoenix Cos. (PNX) Receives SEC Amended Administrative Order; Outlines Filing Timetables Aug 1, 2014 03:01PM

Phoenix Cos. (NYSE: PNX) announced it has entered into an agreement with the U.S. Securities and Exchange Commission (“SEC”) to amend a March 21, 2014 administrative order regarding delayed and certain future SEC filings for both the company and its subsidiary, PHL Variable Insurance Company (“PHL Variable”). The amended administrative order, which was approved by the SEC today, provides that the SEC has settled administrative proceedings against the company and PHL Variable instituted pursuant to Section 21C of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

On June 3, 2014, Phoenix announced a revised timetable for its delayed SEC filings that reflected a departure from the schedule that was part of the March 21, 2014 administrative order because it needed additional time to meet its financial reporting obligations based on its experience with completing its 2012 delayed filings. The company filed its 2012 Form 10-K on April 1, 2014 and completed the last of the 2012 parent and subsidiary filing obligations to the SEC and state insurance regulators on May 5, 2014.

In the amended administrative order, Phoenix and PHL Variable are committed to meet the filing timetables detailed below, which are consistent with the anticipated filing dates provided in the company’s June 3, 2014 announcement. The SEC also imposed additional civil monetary penalties of $100,000 for each entity, and set a formula for additional payments if any filing is not made in accordance with these amended timetables. The additional payment for any filing that does not meet a timetable deadline would be $20,000 per filing for the first week and, for each week or partial week thereafter, the sum of $20,000 plus $5,000 multiplied by the number of full weeks that the filing has already been delinquent.


Date (By No Later Than) Phoenix Filing
Aug. 6, 2014 2013 Annual Report on Form 10-K
Sept. 10, 2014 First Quarter 2013 Form 10-Q

Second Quarter 2013 Form 10-Q

Third Quarter 2013 Form 10-Q

Oct. 17, 2014 First Quarter 2014 Form 10-Q
Oct. 24, 2014 Second Quarter 2014 Form 10-Q
Dec. 5, 2014 Third Quarter 2014 Form 10-Q


Date (By No Later Than) PHL Variable Filing
Aug. 22, 2014 2013 Annual Report on Form 10-K
Sept. 12, 2014 First Quarter 2013 Form 10-Q

Second Quarter 2013 Form 10-Q

Third Quarter 2013 Form 10-Q

Oct. 21, 2014 First Quarter 2014 Form 10-Q
Oct. 28, 2014 Second Quarter 2014 Form 10-Q
Dec. 12, 2014 Third Quarter 2014 Form 10-Q

Except as amended by the most recent administrative order, the March 21, 2014 administrative order remains in effect.

More Corporate News

View Older Stories

Aug 1, 2014 02:01PM Walt Disney (DIS), NCTC Enter Multi-Year Distribution Agreement
Aug 1, 2014 01:42PM Sanofi (SNY): Genzyme Receives Label Expansion for Lumizyme
Aug 1, 2014 01:36PM Interactive Brokers (IBKR) DARTs up 14% YoY in July
Aug 1, 2014 01:30PM Calumet Specialty (CLMT) Acquires Specialty Oilfield Solutions for $30M
Aug 1, 2014 12:51PM Stryker Corp. (SYK) Completes Acquisition of Small Bone Innovations Assets
Aug 1, 2014 12:49PM BioTelemetry's (BEAT) Mednet Served with Subpoena in New Jersey
Aug 1, 2014 11:31AM Allergan (AGN) Files Complaint Against Valeant (VRX), Pershing Square; Alleges Violation of Securities Laws
Aug 1, 2014 10:21AM Hewlett-Packard (HPQ) Will Pay $32.5M to Settle USPS Overcharge Probe
Aug 1, 2014 09:33AM GM (GM) July U.S. Auto Sales Rose 9.4%, Missing Expectations Amid Double-Digit Pickup, SUV Gains
Aug 1, 2014 09:33AM GM (GM) July U.S. Auto Sales Rose 9.4%, Missing Expectations Amid Double-Digit Pickup, SUV Gains
Aug 1, 2014 09:01AM Ford Motor (F) July U.S. Sales Rose 9.5%; Escape, Fusion Bolster Gains
Aug 1, 2014 08:48AM CEL-SCI Corp. (CVM) Surpasss One-Quarter Enrollment in Multikine Phase III
Aug 1, 2014 08:39AM Bacterin Int'l (BONE) Prices 1.14M Common Offering at $5.70/Share
Aug 1, 2014 08:09AM WPCS Int'l (WPCS) Completes Sale of The Pride Group
Aug 1, 2014 07:54AM Biota Pharmaceuticals (BOTA) Reports LANI Met Primary Endpoint in Phase 2
Aug 1, 2014 07:23AM Scientific Games (SGMS) to Acquire Bally Tech (BYI) in $5.1B Deal
Aug 1, 2014 06:44AM Athlon Energy (ATHL) Prices 12.5M Common Secondary Offering at $46.25/Share
Aug 1, 2014 06:27AM Perion Network (PERI) Extends Bing Partnership by Three Years (MSFT)
Aug 1, 2014 06:23AM MakerBot (SSYS) Launches MakerBot Europe
Aug 1, 2014 06:14AM Hill International (HIL) Prices 8.5M Common Stock Offering at $4.25/Share
Jul 31, 2014 05:01PM Alpha Natura (ANR) to 'Right Size' Mining Ops in Virginia
Jul 31, 2014 04:43PM Omnicom Group (OMC) Amends, Extends $2.5B Revolver
Jul 31, 2014 04:38PM Kaman (KAMN) Receives $5.4M Award Modification from JPF
Jul 31, 2014 04:19PM Vertex Pharma (VRTX) Receives EC Approval of KALYDECO in Certain Patients with CF
Jul 31, 2014 04:13PM pSivida (PSDV) ILUVIEN Receives Marketing Apprval from Danish HMA
Jul 31, 2014 02:52PM GlaxoSmithKline plc (GSK), Genmab Report PROLONG Phase III Met Primary Endpoint
Jul 31, 2014 02:49PM RPM International (RPM) to File 10-K Late
Jul 31, 2014 02:24PM Halozyme (HALO), Baxter (BAX) Affirms Positive FDA Panel Vote for HyQvia
Jul 31, 2014 01:55PM Microsoft (MSFT) Responds to Decision in Customer Data Warrant Case
Jul 31, 2014 10:04AM Brookdale Senior Living (BKD) Completes Merger of Emeritus (ESC)
Jul 31, 2014 09:49AM Tyson Foods (TSN) Prices 23.8M Common, 30M TEU Offering
Jul 31, 2014 09:33AM EDAP (EDAP) Slumps; FDA Committee Recommends Against Ablatherm-HIFU Device
Jul 31, 2014 09:27AM Elephant Talk (ETAK) Reports Agreement with HP
Jul 31, 2014 09:20AM Scripps (SSP), Journal (JRN) to Merge Broadcast Operations, Spin-Off Newspapers
Jul 31, 2014 09:19AM BlackBerry (BBRY) Brings BBM to Microsoft's (MSFT) Windows Phone
Jul 31, 2014 09:13AM Ramco-Gershenson Properties Trust (RPT) Prices 6M Common Offering for Proceeds of $98.7M
Jul 31, 2014 09:01AM Gevo (GEVO) Prices 30M Offering at 60c/Unit
Jul 31, 2014 08:35AM Herbalife (HLF) plans China Manufacturing Expansion; Will Make $40M Investment in First Phase
Jul 31, 2014 08:29AM Synthetic Biologics (SYN): Lead Investigator to Present New Data on Trimesta
Jul 31, 2014 08:11AM Everyware Global (EVRY) Gains; Reports Equity Investment, Credit Line Increases to $60M
Jul 31, 2014 08:05AM RF Micro Devices (RFMD), TriQuint (TQNT) Set Special Meeting Date for Sept. 5 Related to Merger
Jul 31, 2014 07:50AM Leidos Holdings (LDOS) Receives Prime Contract from Ameren Illinois
Jul 31, 2014 07:35AM Agrium, Inc. (AGU) Confirms Outage at Vanscoy Potash Mine
Jul 31, 2014 06:47AM Tesla (TSLA), Panasonic Affirm Entering Gigafactory Agreement
Jul 31, 2014 06:08AM Auxilium Pharma (AUXL) Will Receive $10M Milestone for Xiaflex PMDA Submission in Japan
Jul 30, 2014 05:03PM Tessera Technologies (TSRA), Micron (MU) Enter Patent, Tech Licensing Agreements
Jul 30, 2014 04:56PM BioMarin (BMRN) Tops Q2 EPS by 18c, Sells riority Review Voucher for $67.5 Million
Jul 30, 2014 04:18PM Yum! Brands, Inc. (YUM) Terminates Relationship with OSI; Notes Significant, Negative Impact to Same-Store Sales from News Coverage
Jul 30, 2014 04:05PM Dendreon Corp (DNDN) Names Thomas Amick as CEO
Jul 30, 2014 04:02PM Regeneron (REGN) and Sanofi (SNY) Report Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
View Older Stories